4月 2026MDxHealth的市場佔有率分析

The Confirm mdx for Prostate Cancer test addresses prostate biopsy sampling error and the false-negative biopsy dilemma. The test will help "Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. The test will also, “Rule-out” otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures, helping to reduce complications, patient anxiety, and excessive healthcare expenses associated with these procedures.